TOR-induced resistance to toxic adenosine analogs in Leishmania brought about by the internalization and degradation of the adenosine permease.
TOR is an atypical multidrug resistance protein present in the human protozoan parasite, Leishmania. Resistance to the toxic adenosine analog tubercidin was brought about by redirecting the adenosine permease from the plasma membrane to the multivesicular tubule lysosome. The cells became resistant to tubercidin because they were unable to take up and accumulate this toxic purine. The domain, which was recognized by TOR in this internalization pathway, was identified by expressing portions of this transporter in Leishmania and assessing whether they were capable of hindering the multidrug resistance capability of TOR. This approach identified the adenosine permease region spanning Met289 to Trp305. This region was also the epitope recognized by the internalization mechanism. An internal deletion mutant lacking Met289-Trp305 was functionally active but could no longer be internalized in cells with high TOR levels. The internalization and altered trafficking of the adenosine permease by TOR was observed in yeast and human embryonic kidney cells co-expressing these two Leishmania proteins indicating that the internalization process was conserved in evolutionary diverse organisms. The inability of Saccharomyces with a temperature-sensitive ubiquitin ligase to internalize adenosine permease suggested that ubiquitination was involved in this altered trafficking.
Detke
Siegfried
S
Department of Biochemistry and Molecular Biology, University of North Dakota, Grand Forks, ND 58203, USA. sdetke@medicine.nodak.edu
D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D004351:Drug Resistance / Q000502:physiology*; D004705:Endocytosis / Q000502:physiology; D000939:Epitopes / Q000502:physiology; D006801:Humans; D007894:Leishmania mexicana / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D009154:Mutation / Q000502:physiology; D017434:Protein Structure, Tertiary / Q000502:physiology; D021381:Protein Transport / Q000187:drug effects / Q000502:physiology; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism*; D012441:Saccharomyces cerevisiae; D014157:Transcription Factors / Q000378:metabolism*; D014372:Tubercidin / Q000378:metabolism / Q000633:toxicity; D025801:Ubiquitin / Q000378:metabolism
D000939:Epitopes; D026901:Membrane Transport Proteins; C520652:NT1 adenosine permease, Leishmania; C110928:NupM1 protein, Leishmania mexicana; D015800:Protozoan Proteins; D014157:Transcription Factors; D025801:Ubiquitin; D000241:Adenosine; D014372:Tubercidin